Cargando…

UBQLN4 promotes STING proteasomal degradation during cisplatin‐induced DNA damage in triple‐negative breast cancer

Detalles Bibliográficos
Autores principales:	Shoji, Yoshiaki, Yokoe, Takamichi, Kobayashi, Yuta, Murakami, Tomohiro, Bostick, Peter J., Shiloh, Yosef, Hoon, Dave S. B., Bustos, Matias A.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2022
Materias:	Letter to the Editor
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9286529/ https://www.ncbi.nlm.nih.gov/pubmed/35839317 http://dx.doi.org/10.1002/ctm2.985

Ejemplares similares

Genomic Amplification of UBQLN4 Is a Prognostic and Treatment Resistance Factor
por: Kobayashi, Yuta, et al.
Publicado: (2022)

Regulation of MRE11A by UBQLN4 leads to cisplatin resistance in patients with esophageal squamous cell carcinoma
por: Murakami, Tomohiro, et al.
Publicado: (2021)

MiR-181a targets STING to drive PARP inhibitor resistance in BRCA- mutated triple-negative breast cancer and ovarian cancer
por: Bustos, Matias A., et al.
Publicado: (2023)

UBQLN2 Mediates Autophagy-Independent Protein Aggregate Clearance by the Proteasome
por: Hjerpe, Roland, et al.
Publicado: (2016)

Impaired 26S Proteasome Assembly Precedes Neuronal Loss in Mutant UBQLN2 Rats
por: Zhang, Wenjuan, et al.
Publicado: (2021)

Short N-terminal disordered regions and the proline-rich domain are major regulators of phase transitions for full-length UBQLN1, UBQLN2 and UBQLN4
por: Dao, Thuy P., et al.
Publicado: (2023)

Overexpression of UBQLN1 reduces neuropathology in the P497S UBQLN2 mouse model of ALS/FTD
por: Wang, Shaoteng, et al.
Publicado: (2020)

Towards a molecular understanding of the overlapping and distinct roles of UBQLN1 and UBQLN2 in lung cancer progression and metastasis
por: Shah, Parag P., et al.
Publicado: (2022)

Prognostic and predicted significance of Ubqln2 in patients with hepatocellular carcinoma
por: Luo, Yuan‐Deng, et al.
Publicado: (2020)

Global proteomics of Ubqln2-based murine models of ALS
por: Whiteley, Alexandra M., et al.
Publicado: (2020)

UBQLN Family Members Regulate MYC in Lung Adenocarcinoma Cells
por: Shah, Parag P., et al.
Publicado: (2023)

Axon guidance genes modulate neurotoxicity of ALS-associated UBQLN2
por: Kim, Sang Hwa, et al.
Publicado: (2023)

Recent Developments of Circulating Tumor Cell Analysis for Monitoring Cutaneous Melanoma Patients
por: Shoji, Yoshiaki, et al.
Publicado: (2022)

Key role of UBQLN2 in pathogenesis of amyotrophic lateral sclerosis and frontotemporal dementia
por: Renaud, Laurence, et al.
Publicado: (2019)

Serpin neuropathology in the P497S UBQLN2 mouse model of ALS/FTD
por: Higgins, Nicole R., et al.
Publicado: (2021)

Avoidance and Period-Shortening of Neoadjuvant Chemotherapy Against Triple-Negative Breast Cancer in Stages I and II: Importance of Ki-67 Labeling Index and the Recognition of Apocrine-Type Lesions
por: Kubouchi, Koichi, et al.
Publicado: (2020)

A novel ALS-associated variant in UBQLN4 regulates motor axon morphogenesis
por: Edens, Brittany M, et al.
Publicado: (2017)

UBQLN2 restrains the domesticated retrotransposon PEG10 to maintain neuronal health in ALS
por: Black, Holly H, et al.
Publicado: (2023)

UBQLN1 deficiency mediates telomere shortening and IPF through interacting with RPA1
por: Zhou, Haoxian, et al.
Publicado: (2023)

Degradation of Intrinsically Disordered Proteins by the NADH 26S Proteasome
por: Tsvetkov, Peter, et al.
Publicado: (2020)

Mutations in UBQLN2 cause dominant X-linked juvenile and adult onset ALS and ALS/dementia
por: Deng, Han-Xiang, et al.
Publicado: (2011)

Early Impairment of Synaptic and Intrinsic Excitability in Mice Expressing ALS/Dementia-Linked Mutant UBQLN2
por: Radzicki, Daniel, et al.
Publicado: (2016)

No Evidence for Pathogenic Role of UBQLN2 Mutations in Sporadic Amyotrophic Lateral Sclerosis in the Mainland Chinese Population
por: Huang, Xiao, et al.
Publicado: (2017)

UBQLN2 Promotes the Production of Type I Interferon via the TBK1-IRF3 Pathway
por: Chen, Tianhong, et al.
Publicado: (2020)

miR-337-5p promotes the development of cardiac hypertrophy by targeting Ubiquilin-1 (UBQLN1)
por: Ding, Ying, et al.
Publicado: (2021)

Knockdown of UBQLN1 Functions as a Strategy to Inhibit CRC Progression through the ERK-c-Myc Pathway
por: Ni, Ruoxuan, et al.
Publicado: (2023)

NEIL3-mediated proteasomal degradation facilitates the repair of cisplatin-induced DNA damage in human cells
por: Aliyaskarova, Umit, et al.
Publicado: (2023)

Proteasome in action: substrate degradation by the 26S proteasome
por: Sahu, Indrajit, et al.
Publicado: (2021)

Mutant UBQLN2(P497H) in motor neurons leads to ALS-like phenotypes and defective autophagy in rats
por: Chen, Tianhong, et al.
Publicado: (2018)

UBQLN4 promotes progression of HCC via activating wnt-β-catenin pathway and is regulated by miR-370
por: Yu, Yan, et al.
Publicado: (2020)

Silencing UBQLN2 Enhances the Radiosensitivity of Esophageal Squamous Cell Carcinoma (ESCC) via Activating p38 MAPK
por: Wang, Jia-Lin, et al.
Publicado: (2023)

Ubiquitin-proteasome genes as targets for modulation of cisplatin sensitivity in fission yeast
por: Gatti, Laura, et al.
Publicado: (2011)

Integrated Assessment of Circulating Cell-Free MicroRNA Signatures in Plasma of Patients with Melanoma Brain Metastasis
por: Bustos, Matias A., et al.
Publicado: (2020)

Proteasome Inhibitor YSY01A Enhances Cisplatin Cytotoxicity in Cisplatin-Resistant Human Ovarian Cancer Cells
por: Huang, Wei, et al.
Publicado: (2016)

The Impact of ALS-Associated Genes hnRNPA1, MATR3, VCP and UBQLN2 on the Severity of TDP-43 Aggregation
por: Bajc Česnik, Ana, et al.
Publicado: (2020)

(1)H, (15)N, (13)C backbone and Cβ resonance assignments for UBQLN1 UBA and UBAA domains
por: Buel, Gwen R., et al.
Publicado: (2023)

The ATM protein: The importance of being active
por: Shiloh, Yosef, et al.
Publicado: (2012)

The proteasome and the degradation of oxidized proteins: Part II – protein oxidation and proteasomal degradation
por: Jung, Tobias, et al.
Publicado: (2013)

Effects of STING stimulation on macrophages: STING agonists polarize into “classically” or “alternatively” activated macrophages?
por: Ohkuri, Takayuki, et al.
Publicado: (2017)

Activation of cGAS-STING Signal to Inhibit the Proliferation of Bladder Cancer: The Immune Effect of Cisplatin
por: Fu, Guanghou, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_34b07vru42pvhgg6krvcn6s1cd